Hussman Strategic Market Cycle Fund holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Hussman Strategic Market Cycle Fund HSGFX
- NAV / 1-Day Return 5.43 / −0.18 %
- Total Assets 373.2M
-
Adj. Expense Ratio
1.230%
- Expense Ratio 1.150%
- Distribution Fee Level Average
- Share Class Type No Load
- Category Equity Hedged
- Investment Style Small Blend
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 2.43%
- Turnover 410%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:55 AM GMT+0
Morningstar’s Analysis HSGFX
Will HSGFX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings −43.6
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Asset Offset | 58.08 | 230M | — |
Invesco Shrt-Trm Inv Treasury Instl | 39.80 | 157M | Cash and Equivalents |
Option on S&P 500 PR | 1.58 | 6M | — |
Option on Russell 2000 PR USD | 1.49 | 6M | — |
Corcept Therapeutics Inc | 1.22 | 5M | Healthcare |
United Natural Foods Inc | 1.14 | 5M | Consumer Defensive |
The Campbell's Co | 1.13 | 4M | Consumer Defensive |
APA Corp | 1.07 | 4M | Energy |
Etsy Inc | 1.01 | 4M | Consumer Cyclical |
ANI Pharmaceuticals Inc | 0.97 | 4M | Healthcare |